(Q40894950)

24 September 2017

title

The efficacy and safety of intramuscularly administered 15(S) 15 methyl prostaglandin E2 methyl ester for induction of artificial abortion (English)

1 reference

24 September 2017

0 references

1 reference

1

W E Brenner

0 references

author name string

R. Dingfelder

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1190275

24 October 2023

L. G. Staurovsky

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1190275

24 October 2023

language of work or name

English

0 references

publication date

1 September 1975

1 reference

full work available at URL

24 September 2017

https://api.elsevier.com/content/article/PII:0002937875909370?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

https://api.elsevier.com/content/article/PII:0002937875909370?httpAccept=text/plain

24 October 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

American Journal of Obstetrics and Gynecology

24 October 2023

published in

1 reference

24 September 2017

volume

123

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

19-29

1 reference

The effectiveness and complications of abortion by dilatation and vacuum aspiration versus dilatation and rigid metal curettage.

24 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

Oxytocin administration, instillation-to-abortion time, and morbidity associated with saline instillation

24 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

Efficacy and tolerance of intravenous prostaglandins F2α and E2

24 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

Therapeutic abortion by intrauterine instillation of prostaglandins

24 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

Induction of abortion by extra-ammiotic prostaglandin administration

24 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

Therapeutic abortion by intrauterine instillation of prostaglandin E 2

24 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

Action of prostaglandin in the pregnant woman

24 October 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

Termination of second trimester pregnancy with 15 methyl analogues of prostaglandins E 2 and F 2

24 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

Midtrimester abortion with intramuscular injection of 15-methyl-prostaglandin E2

24 October 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

Termination of pregnancy with prostaglandin analogues

24 October 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

Intramuscular administration of 15(S)-15-methylprostaglandin E2-methyl ester for induction of abortion.

24 October 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

Abortifacient efficacy of intravaginal prostaglandin F2α

24 October 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

24 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

Aspirin and indomethacin: Effect on instillation/abortion time of mid-trimester hypertonic saline induced abortion

24 October 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

Reassessment of systemic administration of prostaglandins for induction of midtrimester abortion.

24 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

Mid-trimester abortion with 15 (S) methyl prostaglandin F 2 alpha

24 October 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

Midtrimester abortion induced by serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2α

24 October 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

Dilatation and evacuation at 13 to 15 weeks' gestation versus intra-amniotic saline after 15 weeks' gestation.

24 October 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

Prostaglandin E2 induced abortion with vaginal suppositories in a contraceptive diaphragm

24 October 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

Intrauterine administration of prostaglandin by the extra-amniotic route

24 October 2023

28

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

Laminaria augmentation of intra-amniotic prostaglandin F2 alpha for the induction of mid-trimester abortion

24 October 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

Pretreatment with laminaria tents before mid-trimester abortion with intra-amniotic prostaglandin F2ALPHA.

24 October 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

Prostaglandin-oxytocin abortion: a clinical trial of intra-amniotic prostaglandin F2alpha in combination with intravenous oxytocin

24 October 2023

31

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

The synergistic activity of intra-amniotic prostaglandin F2 alpha and urea in the midtrimester elective abortion

24 October 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-9378(75)90937-0

24 October 2023

Identifiers

0 references

1 reference